Overview
Matrix Surgical USA, headquartered in Atlanta, Georgia, was founded in 2012. The company is a leading entity in the design, manufacture, and distribution of OMNIPORE® porous high-density polyethylene implants. These implants are used primarily in craniofacial reconstructive and aesthetic surgeries, complying with stringent standards set by international authorities such as the FDA, CE, ANVISA, KFDA, and TFDA, ensuring high quality and reliability.
Key Products
- OMNIPORE® Implants: This flagship product line includes a variety of surgical implants catered to facial, neurosurgical, and reconstructive applications.
- Standard and Customized Surgical Implants: Standard offerings include facial shapes for augmentation and reconstructive solutions for defects, while customized solutions use cutting-edge imaging technologies to tailor implants to specific patient needs.
Recent Developments
- On July 31, 2024, Matrix Surgical USA announced the launch of a wholly-owned subsidiary in Brazil, marking significant expansion efforts in the South American market.
Leadership
John O'Shaughnessy serves as the Founder and CEO, bringing extensive experience from senior roles at Stryker and Porex Surgical, Inc. He was instrumental in international revenue growth and recipient of the President’s E-Award for export growth. John holds a BA in Economics from SUNY Potsdam and an MBA from Georgia State University and received the Global Business Alumni Award in 2006.
Jim Perez is the Executive Vice President and Principal, with over 26 years of experience in the medical device industry. Previously, he directed U.S. sales at Porex Surgical Inc. and led sales at FCI Ophthalmics. Jim possesses a B.A. in Business and Economics from St. Anselm College.
Financial Information
Matrix Surgical USA has raised approximately $448,000 in funding, and the company's revenue is estimated at $12.3 million, reflecting robust financial health in the niche market of medical implants.
Contact Information
- Address: 98 Bledsoe Road, Newnan, Georgia 30265
- Phone: 404.855.4592
- Email: info@matrixsurgicalusa.com
Market Position and Strategy
Matrix Surgical USA emphasizes a customer-focused, innovative approach in the craniomaxillofacial implants sector, aiming to strengthen their market position by forming deeper client connections and maintaining product excellence. The company's flagship product, OMNIPORE®, distinguishes itself with over 95 unique biocompatible innovations.
Competitors
Key competitors include:
- Seisa: A global contract manufacturer specializing in Class II and Class III medical devices, providing comprehensive solutions from design to production, serving both North America and Europe.
- RetinaLogik Inc.: Specializes in vision screening technology using VR for eye exams, headquartered in Calgary, Alberta.
- Nexus Medical: Known for anti-reflux needleless connectors within the medical technology sector.
Industry Insights
Matrix Surgical USA operates in the competitive craniomaxillofacial implants market alongside prominent players like DePuy Synthes, Stryker Corporation, and KLS Martin. Through offering unique biocompatible products such as OMNIPORE®, they effectively differentiate themselves to cater to specific market demands.
Professionals within sales or business development can leverage Matrix Surgical USA's industry positioning and competitive differentiators to identify and engage potential clients effectively.
